137 related articles for article (PubMed ID: 36881481)
1. Heterozygous gain-of-function mutations in human STAT1: A case of hemophagocytic lymphohistiocytosis due to chronic mucocutaneous candidiasis in a 17-month-old male.
Ruan P; Zhang Y; Chen H; Chen H; Dong Z
Pediatr Blood Cancer; 2023 Jun; 70(6):e30284. PubMed ID: 36881481
[No Abstract] [Full Text] [Related]
2. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.
Haake K; Wüstefeld T; Merkert S; Lüttge D; Göhring G; Auber B; Baumann U; Lachmann N
Stem Cell Res; 2020 Mar; 43():101713. PubMed ID: 32000109
[TBL] [Abstract][Full Text] [Related]
3. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Carey B; Lambourne J; Porter S; Hodgson T
Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function STAT1 mutation and visceral leishmaniasis.
Lyra PT; Falcão ACAM; Cruz RA; Coelho AVC; Souza EDS; Alencar LCA; Oliveira JB
Einstein (Sao Paulo); 2022; 20():eRC0048. PubMed ID: 36102410
[TBL] [Abstract][Full Text] [Related]
5. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
6. Practical challenges for functional validation of STAT1 gain of function genetic variants.
Albuquerque AS; Maimaris J; McKenna AJ; Lambourne J; Moreira F; Workman S; Megy K; Simeoni I; Lango Allen H; ; Morris EC; Burns SO
Clin Exp Immunol; 2023 Apr; 212(2):166-169. PubMed ID: 36722341
[No Abstract] [Full Text] [Related]
7. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
[TBL] [Abstract][Full Text] [Related]
8. STAT1 gain-of-function and chronic demodicosis.
Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
[TBL] [Abstract][Full Text] [Related]
9. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
10. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis.
Ostadi V; Sherkat R; Migaud M; Modaressadeghi SM; Casanova JL; Puel A; Nekooie-Marnany N; Ganjalikhani-Hakemi M
Med Mycol; 2021 Feb; 59(2):180-188. PubMed ID: 32526033
[TBL] [Abstract][Full Text] [Related]
12. The potential role for topical imiquimod in the treatment of chronic mucocutaneous candidiasis caused by gain-of-function mutation in STAT1: A case-report.
Reis J; van de Veerdonk FL; Carvalho A; Fernandes A; Machado S
Dermatol Ther; 2021 Sep; 34(5):e15043. PubMed ID: 34176198
[No Abstract] [Full Text] [Related]
13. Bronchiectasis and Recurrent Respiratory Infections with a
Huh HJ; Jhun BW; Choi SR; Kim YJ; Yun SA; Nham E; Kong T; Ki CS; Koh WJ
Yonsei Med J; 2018 Oct; 59(8):1004-1007. PubMed ID: 30187709
[TBL] [Abstract][Full Text] [Related]
14. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
[TBL] [Abstract][Full Text] [Related]
15. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
Kunvarjee B; Bidgoli A; Madan RP; Vidal E; McAvoy D; Hosszu KK; Scaradavou A; Spitzer BG; Curran KJ; Cancio M; Harris AC; O'Reilly RJ; Kung AL; Prockop S; Boelens JJ; Oved JH
J Allergy Clin Immunol; 2023 Sep; 152(3):815-817. PubMed ID: 37367708
[No Abstract] [Full Text] [Related]
16. Case Report: Disseminated
Chen K; Tan J; Qian S; Wu S; Chen Q
Front Immunol; 2021; 12():682350. PubMed ID: 34421897
[TBL] [Abstract][Full Text] [Related]
17. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
18. Utility of ruxolitinib in a patient with chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation.
Olivier N; Boralevi F; Fricain JC; Doutre MS
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):e899-e902. PubMed ID: 35696308
[No Abstract] [Full Text] [Related]
19. Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1.
Asano T; Utsumi T; Kagawa R; Karakawa S; Okada S
Clin Exp Immunol; 2023 Apr; 212(2):96-106. PubMed ID: 36420581
[TBL] [Abstract][Full Text] [Related]
20. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
Okada S; Asano T; Moriya K; Boisson-Dupuis S; Kobayashi M; Casanova JL; Puel A
J Clin Immunol; 2020 Nov; 40(8):1065-1081. PubMed ID: 32852681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
